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　　［摘要］　背景与目的：免疫球蛋白G（immunoglobulin G，IgG）是血清和细胞外液中含量 高的免疫
球蛋白，其某个亚类的升高，可能与宫颈上皮内瘤变（cervical intraepithelial neoplasia, CIN）的发
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　　［Abstract］ Background and purpose：The maximum content of immunoglobulin G was found in 
serum and extracellular fluid. The increase of some immunoglobulin G subclasses may closely correlate with the 
occurrence, development and the outcome of cervical lesions. However, the changes of IgG subclasses toward human 
papillomavirus 16-like particles (HPV16VLPs) in the serum of patients are still under investigation. This paper aimed 
to study this issue and also analyze the relationship between the expression of IgG subclasses and different grades of 
cervical lesions. Methods：The expression of IgG subclasses in 32 human papillomavirus, 30 cervical intraepithelial 
neoplasia (CINⅠ), 43 CINⅡ-Ⅲ, 24 hysteromyoma and chronic cervicitis were examined by ELISA.  Results：The 
absorbance value of HPV16-IgG, IgG1 increased with the grade of CIN (P<0.05). The IgG2 dominance (IgG2/IgG1 
ratio>1) from control group was 100%, 87.50% for HPV infection group, 75% for CINⅠ group, compared with that 
from CINⅡ-Ⅲ patients (9.52%) (P<0.05). The positive rate and absorbance value of HPV16-IgG, IgG1, IgG2 from 
HPV16-DNA positive group were significantly higher than those from non-HPV16-DNA positive group (P<0.05). 
There was a moderate correlation between the HPV16-DNA testing and detection of HPV16-IgG.   Conclusion：An 
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increase of the expression of HPV16-IgG and its subclasses in the serum of the patients with cervical precancerous 
lesions, especially those with CINⅡ-Ⅲ, might be associated with duration of HPV infection and severity of cervical 
lesions. An increase of the IgG2 dominance (IgG2/IgG1>1) in serum from low grade cervical lesions group and normal 
control group, might indicate the clearance of HPV infection and the regression of cervical lesions.




































































释,每孔100 μL）；置37 ℃反应30 min，洗涤5
次 ；加入HRP标记的羊抗鼠IgG（1∶20 000稀
释，100 μL孔）；置37 ℃反应30 min，洗涤5
次；每孔加入底物A，B（TMB底物使用液）各



































Tab. 1    Comparison of detection results of serum 
HPV16VLPs-IgG antibodies in each group
（x±s）
Group Cases HPV16 VLPspositive expression n(%)
Ig G
A value 
Study group 105 37(35.24)
　HPV 32 8 (25.00) 0.485±0.037
　CINⅠ 30 8 (26.67) 1.531±0.013
　CINⅡ-Ⅲ 43 21 (48.84) 2.421±0.012

































































Tab. 3    Relationship between IgG2/IgG1 ratio and 
all levels of cervical lesions











































Tab. 2    Comparison of detection results of serum HPV16VLPs- IgG1, IgG2 antibodies in each group
（x±s）
Group n
HPV16 VLPs-IgG1 HPV16 VLPs-IgG2
Positive expression n(%) A value Positive expression  n(%) A value
Study group 105 31(29.52)  31(29.52)
　HPV 32 6(18.75)  0.311±0.020  8(25.00) 0.551±0.042
　CINⅠ 30 7(23.33) 1.104±0.029  6(20.00) 1.686±0.013
　CINⅡ-Ⅲ 43 18(41.86) 1.941±0.038 17(39.53) 1.831±0.064
Control group 24 2(8.33)  0.308±0.019 2(8.33) 1.611±0.021
表 4　HPV16-DNA检测与HPV16VLPs-IgG, IgG1及IgG2检测结果比较
Tab. 4    Comparison of detection results of HPV16-DNA and HPV16VLPs-IgG, IgG1, IgG2 antibodies
Group n
HPV16 VLPs-Ig G HPV16 VLPs-Ig G1, Ig G2
Positive expression n(%) A value Positive expression n(%) A value 
HPV16-DNA(+) 35 26(74.29) 1.564±0.062 26(74.29) 1.365±0.037
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